Your browser doesn't support javascript.
loading
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.
Sundaresan, Tilak K; Sequist, Lecia V; Heymach, John V; Riely, Gregory J; Jänne, Pasi A; Koch, Walter H; Sullivan, James P; Fox, Douglas B; Maher, Robert; Muzikansky, Alona; Webb, Andrew; Tran, Hai T; Giri, Uma; Fleisher, Martin; Yu, Helena A; Wei, Wen; Johnson, Bruce E; Barber, Thomas A; Walsh, John R; Engelman, Jeffrey A; Stott, Shannon L; Kapur, Ravi; Maheswaran, Shyamala; Toner, Mehmet; Haber, Daniel A.
Afiliação
  • Sundaresan TK; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Sequist LV; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Heymach JV; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Riely GJ; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
  • Jänne PA; Department of Medicine, Harvard Medical School, Boston, Massachusetts. Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Koch WH; Roche Molecular Systems, Inc., Pleasanton, California.
  • Sullivan JP; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Fox DB; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Maher R; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Muzikansky A; MGH Biostatistics Center, Boston, Massachusetts.
  • Webb A; EKF Molecular Diagnostics, Ltd., Cardiff, United Kingdom.
  • Tran HT; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Giri U; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fleisher M; Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
  • Yu HA; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
  • Wei W; Roche Molecular Systems, Inc., Pleasanton, California.
  • Johnson BE; Department of Medicine, Harvard Medical School, Boston, Massachusetts. Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Barber TA; BioMEMS Resource Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Walsh JR; BioMEMS Resource Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Engelman JA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Stott SL; Department of Medicine, Harvard Medical School, Boston, Massachusetts. BioMEMS Resource Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Kapur R; BioMEMS Resource Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Maheswaran S; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Surgery, Harvard Medical School, Boston, Massachusetts.
  • Toner M; BioMEMS Resource Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts. Department of Surgery, Harvard Medical School, Boston, Massachusetts.
  • Haber DA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Howard Hughes Medical Institute, Chevy Chase, Maryland. Haber@helix.mgh.harvard.edu.
Clin Cancer Res ; 22(5): 1103-10, 2016 Mar 01.
Article em En | MEDLINE | ID: mdl-26446944
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article